Daily BriefsJapan

Daily Brief Japan: Fancl Corp, Stanley Electric, Heiwa Real Estate, Nippon Electric Glass, Fanuc Corp, M3 Inc, Seven & I Holdings, Monex Group Inc, Kokuyo Co Ltd, Paramount Bed Holdings Co Lt and more

In today’s briefing:

  • Fancl (4921) – Extendy-Extendy-Bumpity-Bumpity
  • Stanley Electric (6923) – Salutary Q1 and BIG Buyback
  • Heiwa Real Estate (8803 JP): Murakami Becomes a Substantial Shareholder
  • Big (Relatively Speaking) NEG (5214 JP) Buyback – Walking The Walk, Faster
  • Fanuc (6954) | Improved Orders and Margins Amid Long-Term Challenges
  • M3: No Tangible Recovery in Earnings Yet
  • Seven & I’s Ito-Yokado Hopes Branded Deli Will Boost Recovery
  • Monex Group Inc (8698 JP): Q1 FY03/25 flash update
  • Kokuyo Co Ltd (7984 JP): 1H FY12/24 flash update
  • Paramount Bed Holdings Co Lt (7817 JP): Q1 FY03/25 flash update


Fancl (4921) – Extendy-Extendy-Bumpity-Bumpity

By Travis Lundy

  • The Kirin Holdings (2503 JP) Tender Offer to buy out minorities in Fancl Corp (4921 JP) closes today. Or at least the current one does. 
  • The original deal announced was light, and the stock has traded above terms since the announcement, with one fund buying up to 7.94%.
  • I expect Kirin to extend and bump next week, or bump/extend now, depending on their visibility on Fancl Q1. 

Stanley Electric (6923) – Salutary Q1 and BIG Buyback

By Travis Lundy

  • Today after the close Stanley Electric (6923 JP) announced a salutary Q1 result which was “ahead of in-line” in most metrics towards unchanged H1 and FY guidance. 
  • The company also announced a BIG on-market buyback at 8.1% of shares out, to be bought back with a delayed start over the 7.5mos starting 13 August.
  • At last price, the buyback is ~10mm shares. The details are interesting and are worth a look. 

Heiwa Real Estate (8803 JP): Murakami Becomes a Substantial Shareholder

By Arun George

  • Murakami’s entity, City Index Eleventh, and daughter reported a 5.05% position in Heiwa Real Estate (8803 JP). The shares were purchased from 24 May to 22 July.
  • Murakami’s average buy-in price is JPY3,907.38, a 6.7% discount to the last close price. Recently, Simplex (the previous largest shareholder) sold its entire stake to Taisei Co Ltd (4649 JP).
  • Murakami’s disclosure suggests two possibilities: the start of an activist campaign or a short-term pump-and-dump play. Recent precedents indicate the latter.

Big (Relatively Speaking) NEG (5214 JP) Buyback – Walking The Walk, Faster

By Travis Lundy

  • Today, Nippon Electric Glass (5214 JP) announced an on-market buyback of up to 7.0mm shares (8.08%) spending up to ¥20bn from tomorrow through end-January 2025.
  • An impressive headline, but fewer shares. Importantly, this follows a ¥20bn buyback from last November. They are moving through their MTMP more quickly than expected.
  • This new buyback is worth about 25% of the inbound cross-holdings. And some of those holders plan to sell. This may be designed to let them sell in the market. 

Fanuc (6954) | Improved Orders and Margins Amid Long-Term Challenges

By Mark Chadwick

  • Fanuc reported slightly better-than-expected Q1 sales and OP forecasts, mainly due to a recovery in sales of FA equipment
  • Fanuc’s results are consistent with a bottoming out of Japan’s machine tool orders in the first half of the year
  • We turn bullish on the stock given the cyclical bottoming out of orders and margins. However, the stock is still not “cheap” and the company faces a number of challenges

M3: No Tangible Recovery in Earnings Yet

By Shifara Samsudeen, ACMA, CGMA

  • M3 Inc (2413 JP) reported 1QFY03/2025 results on Friday. Both revenue and OP for the quarter beat consensus estimates by 3.5% and 11.0% respectively despite earnings continue to decline.
  • Medical Platform segment’s earnings have continued to decline as a result of pharma marketing whose revenues are impacted due to spending cuts by pharmaceutical companies.
  • M3’s share price has declined by more than 35% YTD and we don’t see any tangible recovery in the company’s earnings as overseas and other businesses face challenges.

Seven & I’s Ito-Yokado Hopes Branded Deli Will Boost Recovery

By Michael Causton

  • Deli foods already account for 20% of all food sales in Japan but are growing fast as busier consumers demand more convenience. 
  • Most food chains only offer generic items but, last month, Seven & I’s Ito-Yokado began sales of a branded range called York Deli, aiming to differentiate from competitors.
  • Exclusive ranges will be a key factor as it shifts towards a focus on food but is unlikely to be enough.

Monex Group Inc (8698 JP): Q1 FY03/25 flash update

By Shared Research

  • Consolidated net operating revenue: JPY17.0bn (-16.0% YoY; -2.7% QoQ), with commissions received at JPY8.7bn (-11.5% YoY; +10.0% QoQ).
  • US segment: Net operating revenue USD74.1mn (+4.5% YoY; +0.7% QoQ), SG&A expenses USD59.4mn (-1.1% YoY; -4.5% QoQ).
  • Crypto Asset segment: Net operating revenue JPY3.1bn (+164.3% YoY; -29.6% QoQ), SG&A expenses JPY2.5bn (+55.3% YoY; +22.4% QoQ).

Kokuyo Co Ltd (7984 JP): 1H FY12/24 flash update

By Shared Research

  • Revenue increased by JPY5.1bn (+2.9% YoY), driven by growth in the Furniture and Stationery Businesses.
  • Operating profit declined by JPY97mn (-0.6% YoY) due to lower profit in the Interior Retail business and increased adjustments.
  • Gross profit margin rose to 39.9%, while the SG&A expense ratio increased to 31.1% due to strategic spending.

Paramount Bed Holdings Co Lt (7817 JP): Q1 FY03/25 flash update

By Shared Research

  • Revenue: JPY23.1bn (-4.8% YoY), Operating profit: JPY1.6bn (-51.1% YoY), Recurring profit: JPY2.1bn (-48.9% YoY).
  • Domestic revenue: JPY20.9bn (-4.0% YoY), Overseas revenue: JPY2.2bn (-11.9% YoY), Medical care business revenue: JPY7.9bn (-13.6% YoY).
  • Nursing care business revenue: JPY14.3bn (+2.5% YoY), Health promotion business revenue: JPY2.2bn (-12.2% YoY).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars